Search results
FDA Clears Over-the-Counter Abbott Glucose Monitors
iTech Post· 3 days agoThe Food and Drug Administration (FDA) approved two Abbott products, allowing the company to sell over-the-counter continuous glucose ...
U.S. Senator Chuck Grassley Welcomes Oversight of Over-The-Counter Hearing Aids
Sierra Sun Times· 5 days ago(GAO) report he requested to assess the impacts of the Over-the-Counter (OTC) Hearing Aid Act, a law...
Uses and Benefits of Colloidal Oatmeal
Health via Yahoo News· 1 day agoAs an over-the-counter (OTC) moisturizer, colloidal oatmeal acts as an emollient—a type of moisturizer that creates a barrier over the skin to retain...
NIH collaborates with diagnostics manufacturers on | Newswise
Newswise· 2 days agoTo date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for
Abbott gets FDA clearance for over-the-counter continuous glucose monitors
The Verge· 4 days agoAbbott announced today that the US Food and Drug Administration has cleared two new over-the-counter...
Money & the Law: Hear ye, hear ye: The law regarding hearing aids
Colorado Springs Gazette· 5 days agoTo begin, back in August 2017, in a remarkable (these days) bipartisan effort, Congress passed the ...
Will AirPods Beat Out OTC Hearing Aids as Devices More People Will Use?
CNET· 7 days agoApple hasn't claimed so far that its AirPods are a hearing aid, sound amplification product or...
Weekly Roundup on the Cannabis Sector & Psychedelic Sector week of 6-10-24
Market Exclusive· 4 days agoTop Psychedelic Companies for Week #1: Filament Health Filament Health Corp. ( OTC: FLHLF ) received authorization from both Health Canada and the United States Food ...
Biophytis Announces Filing of an IND Application with the US FDA for its Phase 2 Study in Obesity
Digital Journal· 4 days agoFood and Drug Administration (FDA) regarding its phase 2 OBA clinical study in obesity with BIO101 (20-hydroxyecdysone). The OBA study ...
....S. FDA for IBI343 (TOPO1i anti-CLDN18.2 ADC) as Monotherapy for Advanced Pancreatic Cancer -...
Benzinga· 2 days agoSAN FRANCISCO and SUZHOU, China, June 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes